-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Gain Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2020 to Q3 2025.
- Gain Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 34,998,060, a 32% increase year-over-year.
- Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 22,881,415, a 76% increase from 2023.
- Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 13,011,361, a 9.5% increase from 2022.
- Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 11,883,368, a 17% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)